Search research articles
Contact Us
Filters
Showing results (231-240 of 244) with videos related to
Page
of 25
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 1, 1995
The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches
N Griffon, P Sokoloff, J Diaz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1994
In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes
C Labbé-Jullié, I Dubuc, A Brouard, et al.
L'Encephale
|
July 4, 2008
[Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature]
M-A Crocq, V Camus, B Millet, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1995
Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents
F Sautel, N Griffon, P Sokoloff, et al.
International Clinical Psychopharmacology
|
September 1, 1995
The D3 receptor and its relevance in psychiatry
J C Schwartz, N Griffon, J Diaz, et al.
Clinical Neuropharmacology
|
January 1, 1992
Functional and pharmacological aspects of central neuropeptidergic transmission mediated by neurotensin and neuromedin n
P Kitabgi, F De Nadai, C Labbe-Jullie, et al.
Neuropeptides
|
February 1, 1985
Kelatorphan: a full inhibitor of enkephalin degrading enzymes. Biochemical and pharmacological properties, regional distribution of enkephalinase in rat brain by use of a tritiated derivative
G Waksman, R Bouboutou, P Chaillet, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1987
Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects
B Giros, C Gros, J C Schwartz, et al.
European Journal of Biochemistry
|
December 26, 2001
Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist
J Leprince, H Oulyadi, D Vaudry, et al.
Biochemical Society Transactions
|
February 1, 1996
Functional models for the dopamine D3 receptor
N Griffon, F Sautel, C Pilon, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 244) with videos related to
Sort By:
Page
of 25
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 1, 1995
The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches
N Griffon, P Sokoloff, J Diaz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1994
In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes
C Labbé-Jullié, I Dubuc, A Brouard, et al.
L'Encephale
|
July 4, 2008
[Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature]
M-A Crocq, V Camus, B Millet, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1995
Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents
F Sautel, N Griffon, P Sokoloff, et al.
International Clinical Psychopharmacology
|
September 1, 1995
The D3 receptor and its relevance in psychiatry
J C Schwartz, N Griffon, J Diaz, et al.
Clinical Neuropharmacology
|
January 1, 1992
Functional and pharmacological aspects of central neuropeptidergic transmission mediated by neurotensin and neuromedin n
P Kitabgi, F De Nadai, C Labbe-Jullie, et al.
Neuropeptides
|
February 1, 1985
Kelatorphan: a full inhibitor of enkephalin degrading enzymes. Biochemical and pharmacological properties, regional distribution of enkephalinase in rat brain by use of a tritiated derivative
G Waksman, R Bouboutou, P Chaillet, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1987
Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects
B Giros, C Gros, J C Schwartz, et al.
European Journal of Biochemistry
|
December 26, 2001
Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist
J Leprince, H Oulyadi, D Vaudry, et al.
Biochemical Society Transactions
|
February 1, 1996
Functional models for the dopamine D3 receptor
N Griffon, F Sautel, C Pilon, et al.
Page
of 25